viernes, 29 de enero de 2016

DARZALEX: New Drug Trials Snapshot Posted


A new DRUG TRIALS SNAPSHOT FOR DARZALEX is now available. DARZALEX is a drug used to treat patients with a form of blood cancer called multiple myeloma. It is for patients who have received at least three prior treatments for their cancer. 

Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.

See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.

No hay comentarios:

Publicar un comentario